1.Therapeutic effects of Schistosoma mansoni soluble egg antigen in high fat diet induced dyslipidemia, hepatic and cardiovascular pathology in mice
Toulah, F.H. ; El-Aswad, B.E.W ; Harba, N.M. ; Naguib, Y.M.
Tropical Biomedicine 2018;35(4):893-907
High-fat diet (HFD) can cause hyperlipidemia, fatty liver and cardiovascular
disorders. Herein, we evaluated therapeutic effects and possible underlying mechanisms
of actions of Schistosoma mansoni soluble egg antigen (SEA) against experimental HFD
induced dyslipidemia, hepatic and cardiovascular pathology. Forty Swiss albino mice were
divided into four groups (10 each); mice fed standard diet (SD), mice fed HFD, mice fed
HFD for 8 weeks then infected by S. mansoni cercaria (HFD+I) and mice fed HFD for 8
weeks then treated with SEA (HFD+SEA), all mice were euthanized 16 weeks after starting
the experiment. HFD+SEA mice showed significantly (p<0.001) reduced total cholesterol
(TC), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG), and significantly
(p<0.05) increased high-density lipoprotein cholesterol (HDL-C) comparing to HFD mice
with non-significant difference with HFD+I mice group. Doppler flowmetry showed
significantly (p<0.01) lower arterial resistance and significantly (p<0.05) higher blood
flow velocity in HFD+SEA and HFD+I mice groups than HFD mice. HFD+SEA mice revealed
improving in liver and aortic pathology and these were better than HFD+I mice group.
HFD+SEA and HFD+I mice groups had less myocardium lipid deposits, but still showing
some congested blood vessels. HFD myocardium revealed strong CD34+ expression on
immunohistochemistry study, while that of HFD+SEA showed weak and HFD+I mice had
moderate expressions. HFD+SEA mice had significantly (p<0.01) lower serum IL-1β and
vascular endothelial growth factor (VEGF) and significantly (p<0.001) higher serum
transforming growth factor beta 1 (TGF-β1) and IL-10 than HFD mice with non-significant
difference with HFD+I mice. In conclusion, SEA lowered serum lipids, improved aortic
function, decreased liver and cardiovascular pathology in HFD mice, so, it is recommended
to purify active molecules from SEA to develop anti-dyslipidemic treatment.
2.Giardia duodenalis pathogenicity on immunosuppressed animal model
Wakid, M.H. ; Toulah, F.H. ; Mahjoub, H.A. ; Alsulami, M.N. ; Hikal, W.M.
Tropical Biomedicine 2020;37(No.4):1008-1017
Giardiasis is the major water-borne diarrheal disease present worldwide caused by
the common intestinal parasite, Giardia duodenalis. This work aims to investigate the effect
of G. duodenalis infection pathogenicity in immunosuppressed animals through
histopathological examination. A total of 45 BALB/c mice were divided into four groups; G1
(negative control), G2 (healthy animals exposed to Giardia); G3 (immunosuppressed animals
exposed to Giardia), and G4 (non-exposed immunosuppressed animals). Our study revealed
that G3 was the most affected group with an infection rate of 100%. The animals showed
general weakness, soft stool, and high death rate with severe histopathological changes in
the duodenum and mild degenerative changes in hepatic tissues. In G2, the maximal lesions
in both duodenum and liver were on the 11th day. We spotted damage in the villi, edema in the
central core, and submucosa, in addition to increased cellular infiltration with inflammation
in lamina propria. The presence of the parasites within the villi and the lumen was clear. Most
of the hepatocytes revealed hydropic and fatty changes, also dilated congested central veins
and edema were observed. G3 changes were more intense than G2 with massive Giardia
trophozoites between the intestinal villi, lumen, and extensive fatty liver degeneration.
Immune suppression plays a significant role in the severity of injury with the Giardia parasites
in duodenum and liver cells.